Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: Nationwide propensity score matched study

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Shin, Ju Young ^a   Park, Mi Ju ^a   Lee, Shin Haeng ^a   Choi, So Hyun ^a   Kim, Mi Hee ^a   Choi, Nam Kyong ^b   Lee, Joongyub ^b   Park, Byung Joo ^c  

^a Korea Institute of Drug Safety and Risk Management ^*  (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; QUINUPRAMINE; SERTRALINE; VENLAFAXINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; VERY ELDERLY; CHEMICALLY INDUCED; DEPRESSION; DRUG INTERACTION; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; NORTH KOREA; RISK FACTOR;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA; DEPRESSION; DRUG INTERACTIONS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84940416742     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h3517     Document Type: Article

References (30)

1. Moussavi S, Chatterji S, Verdes E, et al Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-8.
2. Osborn DP, Fletcher AE, Smeeth L, et al Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry 2003;18:623-30.
3. Anglin R, Yuan Y, Moayyedi P, et al Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol 2014;109:811-9.
4. Warner-Schmidt JL, Vanover KE, Chen EY, et al Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 2011;108:9262-7.
5. Skop BP, Brown TM Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12-6.
6. Schafer AI. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 1999;106:25-36S.
7. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008;27:31-40.
8. Huang ES, Khalili H, Strate LL, et al Selective serotonin reuptake inhibitors and risk of gastrointestinal bleeding in two prospective, population-based cohorts. Gastroenterology 2011;1:S137.
9. Abajo F, Gil M, Bryant V, et al Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol 2013;69:691-701.
10. Bak S, Tsiropoulos I, Kjaersgaard JO, et al Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002;33:1465-73.
11. De Abajo FJ, Jick H, Derby L, et al Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000;50:43-7.
12. Kharofa J, Sekar P, Haverbusch M, et al Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 2007;38:3049-51.
13. Johnsen SP, Pedersen L, Friis S, et al Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003;34:387-91.
14. Kwon SM. Payment system reform for health care providers in Korea. Health Policy Plan 2003;18:84-92.
15. Shin JY, Choi NK, Jung SY, et al Overlapping medication associated with healthcare switching among Korean elderly diabetic patients. J Korean Med Sci 2011;26:1461-8.
16. Park BJ, Sung JH, Park KD, et al Report of the evaluation for validity of discharged diagnoses in Korean health insurance database. Seoul National University, 2003:19-52.
17. Katzung BG, Masters SB, Trevor AJ Basic and clinical pharmacology. 12th ed. McGraw-Hill, 2012.
18. Quan H, Sundararajan V, Halfon P, et al Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
19. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS Users Group international conference; 2001. SAS Institute, 2001.
20. A unified approach to measuring the effect size between two groups using SAS®. SAS Global Forum, Orlando FL, 2012.
21. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul C 2009;38:1228-34.
22. Austin PC. The use of propensity score methods with survival or timetoevent outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 2014;33:1242-58.
23. Andersen PK, Geskus RB, de Witte T, et al Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-70.
24. De Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65:795-803.
25. Tatsumi M, Groshan K, Blakely RD, et al Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997;340:249-58.
26. Jung SY, Choi NK, Kim JY, et al Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology 2011;77:1229-34.
27. Korean Ministry of Health and Welfare. Pilot test of National Cardiovascular Disease Surveillance System. Ministry of Health and Welfare, 2000.
28. Krarup LH, Boysen G, Janjua H, et al Validity of stroke diagnoses in a national register of patients. Neuroepidemiology 2007;28:150-4.
29. Leppala JM, Virtamo J, Heinonen O P. Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 1999;15:155-60.
30. Liu L, Reeder B, Shuaib A, et al Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Cerebrovasc Dis 1999;9:224-30.